Total Funding
88
61
Total FundingGrant raised
Growth Score
-4 pts
Heat Score
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
58616
StratifiCare is a medical device that utilizes severe dengue diagnostics.
- Anthony Chua: Co-Founder and CEO
- Tiffany Fan Lin: Co-founder and Quality Manager
About the Company
StratifiCare is a medical company that focuses on the development and manufacturing of in vitro diagnostic medical devices it provides solutions for personalized medicine. StratifiCare features a panel of biomarkers which are able to determine the progress of dengue fever.
The company was founded on July 13, 2015, and headquartered in Singapore.
